Oxford Gene Technology Company Profile

20:27 EDT 17th March 2018 | BioPortfolio

DNA microassays consisting of in situ synthesises oligonucleotide probes.


BioBuisness Centre
United Kingdom


Phone: 44 1865 405118
Fax: 44 1865 405120

News Articles [1770 Associated News Articles listed on BioPortfolio]

Oxford Gene Technology: Mike Evans. Providers of innovative genetics research and biomarker solutions to advance molecular medicine

Mike Evans, CEO of Oxford Gene Technology talks to Fintan Walton about OGT's new diagnostic techiques and innovative research into Lupus, Prostate and Colorectal cancers.

Oxford BioMedica, Bioverativ to Develop Lentiviral Vectors for Hemophilia Gene Therapy

Oxford BioMedica said today it will partner with Bioverativ to develop and manufacture lentiviral vectors designed to treat hemophilia, through a collaboration that could generate up to $105 million-p...

Oxford Nanopore's tech reaches genome sequencing landmark

A  new technique for gene sequencing has produced the most complete human genome ever assembled with a single technology - the nanapore, developed by UK company Oxford Nanopore Technologies. The m...

Oxford BioMedica wins second $100 million gene therapy contract

LONDON (Reuters) - Britain's Oxford BioMedica has won a second $100 million contract to supply gene therapy material, this time from Bioverativ, which agreed last month to be acquired by Sanofi for $1...

Oxford BioMedica Wins $105M Gene Therapy Contract From Bioverativ

The deal includes a licence to use OXB's LentiVector Enabled technology and access to its industrial-scale manufacturing technology.

Affymetrix Purchases License to Southern DNA Array Patents

Affymetrix Inc. (Santa Clara, CA) has purchased a license to the Southern DNA array patents owned by Oxford Gene Technology (OGT; Oxford, England)...

Oxford BioMedica set to earn $100 million in deal with Sanofi takeover target

UK gene cell therapy designer Oxford BioMedica’s shares jumped as much as 11.2% to 12.30 pence this…

Oxford Spin-out Moves Gene Therapy For Blindness Into Phase III Trial

Nightstar Therapeutics will begin the first Phase III trial for a gene therapy targeting choroideremia, a rare disorder leading to complete blindness. Nightstar will launch the first-ever Phase III t...

PubMed Articles [3309 Associated PubMed Articles listed on BioPortfolio]

Real-time demultiplexing Nanopore barcoded sequencing data with npBarcode.

The recent introduction of a barcoding protocol for Oxford Nanopore sequencing has increased the versatility of the technology. Several bioinformatics tools have been developed to demultiplex barcoded...

Molecular tools for gene manipulation in filamentous fungi.

Functional genomics of filamentous fungi has gradually uncovered gene information for constructing 'cell factories' and controlling pathogens. Available gene manipulation methods of filamentous fungi ...

CESAR 2.0 substantially improves speed and accuracy of comparative gene annotation.

Homology-based gene prediction is a powerful concept to annotate newly sequenced genomes. We have previously demonstrated that whole genome alignments can be utilized for accurate comparative coding g...

Pressing diseases that represent promising targets for gene therapy.

Over time, there has been a growing interest in the application of gene therapy within the healthcare industry as demonstrated by the nearly 3,000 clinical trials associated with gene therapy that are...

Gestational age-specific perinatal mortality rates for assisted reproductive technology (ART) and other births.

Is perinatal mortality rate higher among births born following assisted reproductive technology (ART) compared to non-ART births?

Clinical Trials [2983 Associated Clinical Trials listed on BioPortfolio]

Oxford Partial Knee Replacement. A Randomized Clinical Trial of Three Implant Types

The purpose of this scientific study is to clarify whether there is a relationship between the appearance of radiolucent lines in bone-cement interphase of the tibial component of the diff...

Comparison of Oxford UKA and Sigma UKA With RSA.

Comparison of two unicompartmental knee arthroplasties (UKA), to see if Sigma UKA performs equally good as the Oxford UKA. The study focuses on how well the arthroplasty is fixated to the ...

A Clinical Investigation of the Oxford® Meniscal Unicompartmental Knee System

The purpose of this study is to collect information on complications and survivorship of patients implanted with the Oxford™ Meniscal Unicompartmental Knee System at multiple sites in th...

Oxford® Partial Knee Kinematics Gait Analysis Study

The objective of this study is to compare the effect on gait of unicompartmental knee arthroplasty (UKA), using the Oxford® Partial Knee, versus total knee arthroplasty (TKA), using the V...

Outcome Analysis of the Oxford Partial Knee Arthroplasty

Prospectively monitor the patients receiving the Oxford Partial knee arthroplasty

Companies [1050 Associated Companies listed on BioPortfolio]

Oxford Healthcare Technology

Oxford Healthcare Technology is a staffing firm that leverages their recruiting expertise to deliver experienced healthcare professionals and project teams for consulting engageme...

Oxford BioMedica

Oxford BioMedica advanced gene therapy techniques.

BioMedica Inc.

Oxford BioMedica (LSE: OXB) is a biopharmaceutical company specialising in the development of novel gene-based therapeutics with a focus on the areas of oncology and neurotherapy. The Company was esta...

Oxford Gene Technology

DNA microassays consisting of in situ synthesises oligonucleotide probes.

Oxford Resource Partners, LP

Oxford Resource Partners, LP is a low cost producer of high value steam coal in Northern Appalachia and the Illinois Basin. Oxford markets its coal primarily to large electric utilities with coal-fir...

More Information about "Oxford Gene Technology" on BioPortfolio

We have published hundreds of Oxford Gene Technology news stories on BioPortfolio along with dozens of Oxford Gene Technology Clinical Trials and PubMed Articles about Oxford Gene Technology for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Oxford Gene Technology Companies in our database. You can also find out about relevant Oxford Gene Technology Drugs and Medications on this site too.

Quick Search


Relevant Topic

DNA sequencing
DNA sequencing is the process of determining the precise order of nucleotides within a DNA molecule. During DNA sequencing, the bases of a small fragment of DNA are sequentially identified from signals emitted as each fragment is re-synthesized from a ...

Corporate Database Quicklinks

Searches Linking to this Company Record